nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NR0B1—Dexamethasone—psoriatic arthritis	0.711	1	CbGbCtD
Vorinostat—HDAC1—manus—psoriatic arthritis	0.0223	0.235	CbGeAlD
Vorinostat—HDAC1—manual digit—psoriatic arthritis	0.0218	0.23	CbGeAlD
Vorinostat—NCOR1—skin of body—psoriatic arthritis	0.00721	0.076	CbGeAlD
Vorinostat—HDAC8—tendon—psoriatic arthritis	0.00648	0.0684	CbGeAlD
Vorinostat—HDAC3—skin of body—psoriatic arthritis	0.00632	0.0666	CbGeAlD
Vorinostat—HDAC4—tendon—psoriatic arthritis	0.0063	0.0665	CbGeAlD
Vorinostat—HDAC1—skin of body—psoriatic arthritis	0.00579	0.061	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Methotrexate—psoriatic arthritis	0.00528	0.0286	CcSEcCtD
Vorinostat—Ureteric obstruction—Methotrexate—psoriatic arthritis	0.00528	0.0286	CcSEcCtD
Vorinostat—Proteinuria—Auranofin—psoriatic arthritis	0.00509	0.0276	CcSEcCtD
Vorinostat—Protein urine present—Auranofin—psoriatic arthritis	0.00502	0.0272	CcSEcCtD
Vorinostat—HDAC3—tendon—psoriatic arthritis	0.00481	0.0507	CbGeAlD
Vorinostat—Thromboembolism—Prednisolone—psoriatic arthritis	0.00449	0.0243	CcSEcCtD
Vorinostat—HDAC1—tendon—psoriatic arthritis	0.0044	0.0465	CbGeAlD
Vorinostat—HDAC9—tendon—psoriatic arthritis	0.00433	0.0457	CbGeAlD
Vorinostat—Thromboembolism—Triamcinolone—psoriatic arthritis	0.00413	0.0223	CcSEcCtD
Vorinostat—Thromboembolism—Methylprednisolone—psoriatic arthritis	0.00412	0.0223	CcSEcCtD
Vorinostat—Thromboembolism—Betamethasone—psoriatic arthritis	0.00374	0.0203	CcSEcCtD
Vorinostat—Thromboembolism—Dexamethasone—psoriatic arthritis	0.00374	0.0203	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.00344	0.0186	CcSEcCtD
Vorinostat—Thromboembolism—Prednisone—psoriatic arthritis	0.00326	0.0176	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00325	0.0176	CcSEcCtD
Vorinostat—HDAC2—skin of body—psoriatic arthritis	0.00291	0.0307	CbGeAlD
Vorinostat—Embolism venous—Prednisolone—psoriatic arthritis	0.00283	0.0153	CcSEcCtD
Vorinostat—Pancytopenia—Auranofin—psoriatic arthritis	0.00267	0.0144	CcSEcCtD
Vorinostat—Neutropenia—Auranofin—psoriatic arthritis	0.00262	0.0142	CcSEcCtD
Vorinostat—Embolism venous—Triamcinolone—psoriatic arthritis	0.0026	0.0141	CcSEcCtD
Vorinostat—Embolism venous—Methylprednisolone—psoriatic arthritis	0.00259	0.014	CcSEcCtD
Vorinostat—Weight decreased—Auranofin—psoriatic arthritis	0.00254	0.0137	CcSEcCtD
Vorinostat—HDAC1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriatic arthritis	0.00248	0.248	CbGpPWpGaD
Vorinostat—Embolism venous—Dexamethasone—psoriatic arthritis	0.00236	0.0128	CcSEcCtD
Vorinostat—Embolism venous—Betamethasone—psoriatic arthritis	0.00236	0.0128	CcSEcCtD
Vorinostat—Embolism—Prednisolone—psoriatic arthritis	0.00222	0.012	CcSEcCtD
Vorinostat—HDAC2—tendon—psoriatic arthritis	0.00221	0.0234	CbGeAlD
Vorinostat—Embolism venous—Prednisone—psoriatic arthritis	0.00205	0.0111	CcSEcCtD
Vorinostat—Embolism—Triamcinolone—psoriatic arthritis	0.00204	0.0111	CcSEcCtD
Vorinostat—Embolism—Methylprednisolone—psoriatic arthritis	0.00204	0.011	CcSEcCtD
Vorinostat—Alopecia—Auranofin—psoriatic arthritis	0.00199	0.0107	CcSEcCtD
Vorinostat—Dysgeusia—Auranofin—psoriatic arthritis	0.00192	0.0104	CcSEcCtD
Vorinostat—Embolism—Dexamethasone—psoriatic arthritis	0.00185	0.01	CcSEcCtD
Vorinostat—Embolism—Betamethasone—psoriatic arthritis	0.00185	0.01	CcSEcCtD
Vorinostat—Anaemia—Auranofin—psoriatic arthritis	0.00181	0.00979	CcSEcCtD
Vorinostat—Abscess—Prednisolone—psoriatic arthritis	0.0018	0.00976	CcSEcCtD
Vorinostat—Angioedema—Auranofin—psoriatic arthritis	0.00179	0.00968	CcSEcCtD
Vorinostat—Leukopenia—Auranofin—psoriatic arthritis	0.00175	0.00948	CcSEcCtD
Vorinostat—Abscess—Triamcinolone—psoriatic arthritis	0.00166	0.00898	CcSEcCtD
Vorinostat—Abscess—Methylprednisolone—psoriatic arthritis	0.00165	0.00896	CcSEcCtD
Vorinostat—Embolism—Prednisone—psoriatic arthritis	0.00161	0.00874	CcSEcCtD
Vorinostat—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00156	0.00846	CcSEcCtD
Vorinostat—Anorexia—Auranofin—psoriatic arthritis	0.00152	0.00824	CcSEcCtD
Vorinostat—Abscess—Dexamethasone—psoriatic arthritis	0.0015	0.00814	CcSEcCtD
Vorinostat—Abscess—Betamethasone—psoriatic arthritis	0.0015	0.00814	CcSEcCtD
Vorinostat—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.00142	0.00771	CcSEcCtD
Vorinostat—Decreased appetite—Auranofin—psoriatic arthritis	0.00139	0.00751	CcSEcCtD
Vorinostat—Constipation—Auranofin—psoriatic arthritis	0.00136	0.00739	CcSEcCtD
Vorinostat—Embolism—Methotrexate—psoriatic arthritis	0.00135	0.00731	CcSEcCtD
Vorinostat—Abscess—Prednisone—psoriatic arthritis	0.00131	0.00709	CcSEcCtD
Vorinostat—Pruritus—Auranofin—psoriatic arthritis	0.00113	0.00611	CcSEcCtD
Vorinostat—Abscess—Methotrexate—psoriatic arthritis	0.00109	0.00593	CcSEcCtD
Vorinostat—Diarrhoea—Auranofin—psoriatic arthritis	0.00109	0.00591	CcSEcCtD
Vorinostat—Vomiting—Auranofin—psoriatic arthritis	0.00101	0.00549	CcSEcCtD
Vorinostat—Proteinuria—Methotrexate—psoriatic arthritis	0.000986	0.00534	CcSEcCtD
Vorinostat—Protein urine present—Methotrexate—psoriatic arthritis	0.000972	0.00526	CcSEcCtD
Vorinostat—NR0B1—Regulation of Androgen receptor activity—REL—psoriatic arthritis	0.000971	0.0971	CbGpPWpGaD
Vorinostat—Nausea—Auranofin—psoriatic arthritis	0.000948	0.00513	CcSEcCtD
Vorinostat—Sepsis—Prednisone—psoriatic arthritis	0.0009	0.00487	CcSEcCtD
Vorinostat—Lethargy—Betamethasone—psoriatic arthritis	0.000882	0.00477	CcSEcCtD
Vorinostat—Lethargy—Dexamethasone—psoriatic arthritis	0.000882	0.00477	CcSEcCtD
Vorinostat—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.000866	0.00469	CcSEcCtD
Vorinostat—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000787	0.00426	CcSEcCtD
Vorinostat—Hypokalaemia—Betamethasone—psoriatic arthritis	0.000786	0.00426	CcSEcCtD
Vorinostat—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.000786	0.00426	CcSEcCtD
Vorinostat—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000782	0.00423	CcSEcCtD
Vorinostat—Lethargy—Prednisone—psoriatic arthritis	0.000768	0.00416	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000765	0.00414	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000752	0.00407	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—psoriatic arthritis	0.000752	0.00407	CcSEcCtD
Vorinostat—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000723	0.00392	CcSEcCtD
Vorinostat—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000722	0.00391	CcSEcCtD
Vorinostat—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000719	0.00389	CcSEcCtD
Vorinostat—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000718	0.00389	CcSEcCtD
Vorinostat—Hypokalaemia—Prednisone—psoriatic arthritis	0.000685	0.00371	CcSEcCtD
Vorinostat—Weight decreased—Dexamethasone—psoriatic arthritis	0.000676	0.00366	CcSEcCtD
Vorinostat—Weight decreased—Betamethasone—psoriatic arthritis	0.000676	0.00366	CcSEcCtD
Vorinostat—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000674	0.00365	CcSEcCtD
Vorinostat—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000674	0.00365	CcSEcCtD
Vorinostat—HDAC1—Regulation of Androgen receptor activity—REL—psoriatic arthritis	0.000673	0.0673	CbGpPWpGaD
Vorinostat—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000666	0.00361	CcSEcCtD
Vorinostat—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000656	0.00355	CcSEcCtD
Vorinostat—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000656	0.00355	CcSEcCtD
Vorinostat—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000653	0.00353	CcSEcCtD
Vorinostat—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000653	0.00353	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—psoriatic arthritis	0.000642	0.00347	CcSEcCtD
Vorinostat—Neutropenia—Prednisone—psoriatic arthritis	0.000608	0.00329	CcSEcCtD
Vorinostat—Weight decreased—Prednisone—psoriatic arthritis	0.000588	0.00319	CcSEcCtD
Vorinostat—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000587	0.00318	CcSEcCtD
Vorinostat—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000572	0.00309	CcSEcCtD
Vorinostat—Angioedema—Prednisolone—psoriatic arthritis	0.00057	0.00308	CcSEcCtD
Vorinostat—Myocardial infarction—Prednisone—psoriatic arthritis	0.000568	0.00308	CcSEcCtD
Vorinostat—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000562	0.00304	CcSEcCtD
Vorinostat—Syncope—Prednisolone—psoriatic arthritis	0.000559	0.00303	CcSEcCtD
Vorinostat—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000548	0.00297	CcSEcCtD
Vorinostat—Alopecia—Betamethasone—psoriatic arthritis	0.000528	0.00286	CcSEcCtD
Vorinostat—Alopecia—Dexamethasone—psoriatic arthritis	0.000528	0.00286	CcSEcCtD
Vorinostat—Angioedema—Triamcinolone—psoriatic arthritis	0.000524	0.00284	CcSEcCtD
Vorinostat—Angioedema—Methylprednisolone—psoriatic arthritis	0.000523	0.00283	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—psoriatic arthritis	0.000516	0.00279	CcSEcCtD
Vorinostat—Syncope—Triamcinolone—psoriatic arthritis	0.000514	0.00278	CcSEcCtD
Vorinostat—Syncope—Methylprednisolone—psoriatic arthritis	0.000513	0.00278	CcSEcCtD
Vorinostat—Neutropenia—Methotrexate—psoriatic arthritis	0.000508	0.00275	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000505	0.00273	CcSEcCtD
Vorinostat—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000504	0.00273	CcSEcCtD
Vorinostat—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000503	0.00272	CcSEcCtD
Vorinostat—Shock—Prednisolone—psoriatic arthritis	0.000501	0.00271	CcSEcCtD
Vorinostat—Cough—Triamcinolone—psoriatic arthritis	0.0005	0.00271	CcSEcCtD
Vorinostat—Dry mouth—Triamcinolone—psoriatic arthritis	0.000477	0.00259	CcSEcCtD
Vorinostat—Angioedema—Betamethasone—psoriatic arthritis	0.000475	0.00257	CcSEcCtD
Vorinostat—Angioedema—Dexamethasone—psoriatic arthritis	0.000475	0.00257	CcSEcCtD
Vorinostat—Syncope—Betamethasone—psoriatic arthritis	0.000467	0.00253	CcSEcCtD
Vorinostat—Syncope—Dexamethasone—psoriatic arthritis	0.000467	0.00253	CcSEcCtD
Vorinostat—Infection—Triamcinolone—psoriatic arthritis	0.000465	0.00252	CcSEcCtD
Vorinostat—Infection—Methylprednisolone—psoriatic arthritis	0.000464	0.00251	CcSEcCtD
Vorinostat—Shock—Triamcinolone—psoriatic arthritis	0.00046	0.00249	CcSEcCtD
Vorinostat—Alopecia—Prednisone—psoriatic arthritis	0.00046	0.00249	CcSEcCtD
Vorinostat—Shock—Methylprednisolone—psoriatic arthritis	0.000459	0.00249	CcSEcCtD
Vorinostat—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000457	0.00248	CcSEcCtD
Vorinostat—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000457	0.00248	CcSEcCtD
Vorinostat—HDAC1—Glucocorticoid receptor regulatory network—IL13—psoriatic arthritis	0.000434	0.0434	CbGpPWpGaD
Vorinostat—Infection—Dexamethasone—psoriatic arthritis	0.000422	0.00228	CcSEcCtD
Vorinostat—Infection—Betamethasone—psoriatic arthritis	0.000422	0.00228	CcSEcCtD
Vorinostat—Anaemia—Prednisone—psoriatic arthritis	0.000419	0.00227	CcSEcCtD
Vorinostat—Shock—Dexamethasone—psoriatic arthritis	0.000418	0.00226	CcSEcCtD
Vorinostat—Shock—Betamethasone—psoriatic arthritis	0.000418	0.00226	CcSEcCtD
Vorinostat—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000416	0.00225	CcSEcCtD
Vorinostat—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000416	0.00225	CcSEcCtD
Vorinostat—Angioedema—Prednisone—psoriatic arthritis	0.000414	0.00224	CcSEcCtD
Vorinostat—Syncope—Prednisone—psoriatic arthritis	0.000406	0.0022	CcSEcCtD
Vorinostat—Anorexia—Betamethasone—psoriatic arthritis	0.000405	0.00219	CcSEcCtD
Vorinostat—Anorexia—Dexamethasone—psoriatic arthritis	0.000405	0.00219	CcSEcCtD
Vorinostat—Fatigue—Triamcinolone—psoriatic arthritis	0.000404	0.00218	CcSEcCtD
Vorinostat—Fatigue—Methylprednisolone—psoriatic arthritis	0.000403	0.00218	CcSEcCtD
Vorinostat—Loss of consciousness—Prednisone—psoriatic arthritis	0.000398	0.00216	CcSEcCtD
Vorinostat—Chills—Methotrexate—psoriatic arthritis	0.00039	0.00211	CcSEcCtD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000386	0.0386	CbGpPWpGaD
Vorinostat—Alopecia—Methotrexate—psoriatic arthritis	0.000384	0.00208	CcSEcCtD
Vorinostat—HDAC1—IL-6 signaling pathway—CRP—psoriatic arthritis	0.000383	0.0383	CbGpPWpGaD
Vorinostat—Dysgeusia—Methotrexate—psoriatic arthritis	0.000371	0.00201	CcSEcCtD
Vorinostat—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00037	0.002	CcSEcCtD
Vorinostat—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000369	0.002	CcSEcCtD
Vorinostat—Decreased appetite—Betamethasone—psoriatic arthritis	0.000369	0.002	CcSEcCtD
Vorinostat—Infection—Prednisone—psoriatic arthritis	0.000367	0.00199	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000367	0.00198	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000367	0.00198	CcSEcCtD
Vorinostat—Fatigue—Betamethasone—psoriatic arthritis	0.000366	0.00198	CcSEcCtD
Vorinostat—Fatigue—Dexamethasone—psoriatic arthritis	0.000366	0.00198	CcSEcCtD
Vorinostat—Shock—Prednisone—psoriatic arthritis	0.000364	0.00197	CcSEcCtD
Vorinostat—Anorexia—Prednisone—psoriatic arthritis	0.000353	0.00191	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—psoriatic arthritis	0.00035	0.0019	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—psoriatic arthritis	0.000339	0.00184	CcSEcCtD
Vorinostat—Dizziness—Prednisolone—psoriatic arthritis	0.000337	0.00182	CcSEcCtD
Vorinostat—Asthenia—Triamcinolone—psoriatic arthritis	0.000336	0.00182	CcSEcCtD
Vorinostat—Body temperature increased—Betamethasone—psoriatic arthritis	0.000336	0.00182	CcSEcCtD
Vorinostat—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000336	0.00182	CcSEcCtD
Vorinostat—Asthenia—Methylprednisolone—psoriatic arthritis	0.000335	0.00181	CcSEcCtD
Vorinostat—Pruritus—Triamcinolone—psoriatic arthritis	0.000331	0.00179	CcSEcCtD
Vorinostat—Cough—Methotrexate—psoriatic arthritis	0.00033	0.00179	CcSEcCtD
Vorinostat—Pruritus—Methylprednisolone—psoriatic arthritis	0.00033	0.00179	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—psoriatic arthritis	0.000322	0.00175	CcSEcCtD
Vorinostat—Decreased appetite—Prednisone—psoriatic arthritis	0.000321	0.00174	CcSEcCtD
Vorinostat—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00032	0.00173	CcSEcCtD
Vorinostat—Fatigue—Prednisone—psoriatic arthritis	0.000319	0.00173	CcSEcCtD
Vorinostat—Headache—Prednisolone—psoriatic arthritis	0.000319	0.00173	CcSEcCtD
Vorinostat—Constipation—Prednisone—psoriatic arthritis	0.000316	0.00171	CcSEcCtD
Vorinostat—Dizziness—Triamcinolone—psoriatic arthritis	0.000309	0.00168	CcSEcCtD
Vorinostat—Dizziness—Methylprednisolone—psoriatic arthritis	0.000309	0.00167	CcSEcCtD
Vorinostat—Infection—Methotrexate—psoriatic arthritis	0.000307	0.00166	CcSEcCtD
Vorinostat—Asthenia—Betamethasone—psoriatic arthritis	0.000305	0.00165	CcSEcCtD
Vorinostat—Asthenia—Dexamethasone—psoriatic arthritis	0.000305	0.00165	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000303	0.00164	CcSEcCtD
Vorinostat—Nausea—Prednisolone—psoriatic arthritis	0.000302	0.00164	CcSEcCtD
Vorinostat—Pruritus—Dexamethasone—psoriatic arthritis	0.0003	0.00163	CcSEcCtD
Vorinostat—Pruritus—Betamethasone—psoriatic arthritis	0.0003	0.00163	CcSEcCtD
Vorinostat—Vomiting—Triamcinolone—psoriatic arthritis	0.000298	0.00161	CcSEcCtD
Vorinostat—Vomiting—Methylprednisolone—psoriatic arthritis	0.000297	0.00161	CcSEcCtD
Vorinostat—Anorexia—Methotrexate—psoriatic arthritis	0.000295	0.0016	CcSEcCtD
Vorinostat—Headache—Triamcinolone—psoriatic arthritis	0.000293	0.00159	CcSEcCtD
Vorinostat—Headache—Methylprednisolone—psoriatic arthritis	0.000293	0.00158	CcSEcCtD
Vorinostat—Body temperature increased—Prednisone—psoriatic arthritis	0.000292	0.00158	CcSEcCtD
Vorinostat—Diarrhoea—Betamethasone—psoriatic arthritis	0.000291	0.00157	CcSEcCtD
Vorinostat—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000291	0.00157	CcSEcCtD
Vorinostat—Dizziness—Dexamethasone—psoriatic arthritis	0.000281	0.00152	CcSEcCtD
Vorinostat—Dizziness—Betamethasone—psoriatic arthritis	0.000281	0.00152	CcSEcCtD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—IL13—psoriatic arthritis	0.00028	0.028	CbGpPWpGaD
Vorinostat—Nausea—Triamcinolone—psoriatic arthritis	0.000278	0.00151	CcSEcCtD
Vorinostat—Nausea—Methylprednisolone—psoriatic arthritis	0.000277	0.0015	CcSEcCtD
Vorinostat—Vomiting—Dexamethasone—psoriatic arthritis	0.00027	0.00146	CcSEcCtD
Vorinostat—Vomiting—Betamethasone—psoriatic arthritis	0.00027	0.00146	CcSEcCtD
Vorinostat—Decreased appetite—Methotrexate—psoriatic arthritis	0.000269	0.00145	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000267	0.00144	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—psoriatic arthritis	0.000266	0.00144	CcSEcCtD
Vorinostat—HDAC11—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000266	0.0267	CbGpPWpGaD
Vorinostat—Headache—Betamethasone—psoriatic arthritis	0.000266	0.00144	CcSEcCtD
Vorinostat—Headache—Dexamethasone—psoriatic arthritis	0.000266	0.00144	CcSEcCtD
Vorinostat—Asthenia—Prednisone—psoriatic arthritis	0.000265	0.00144	CcSEcCtD
Vorinostat—Pruritus—Prednisone—psoriatic arthritis	0.000262	0.00142	CcSEcCtD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.00026	0.026	CbGpPWpGaD
Vorinostat—Diarrhoea—Prednisone—psoriatic arthritis	0.000253	0.00137	CcSEcCtD
Vorinostat—Nausea—Betamethasone—psoriatic arthritis	0.000252	0.00137	CcSEcCtD
Vorinostat—Nausea—Dexamethasone—psoriatic arthritis	0.000252	0.00137	CcSEcCtD
Vorinostat—HDAC4—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000245	0.0245	CbGpPWpGaD
Vorinostat—Dizziness—Prednisone—psoriatic arthritis	0.000245	0.00132	CcSEcCtD
Vorinostat—Body temperature increased—Methotrexate—psoriatic arthritis	0.000244	0.00132	CcSEcCtD
Vorinostat—Vomiting—Prednisone—psoriatic arthritis	0.000235	0.00127	CcSEcCtD
Vorinostat—Headache—Prednisone—psoriatic arthritis	0.000232	0.00125	CcSEcCtD
Vorinostat—HDAC6—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000223	0.0223	CbGpPWpGaD
Vorinostat—Asthenia—Methotrexate—psoriatic arthritis	0.000222	0.0012	CcSEcCtD
Vorinostat—Nausea—Prednisone—psoriatic arthritis	0.00022	0.00119	CcSEcCtD
Vorinostat—Pruritus—Methotrexate—psoriatic arthritis	0.000219	0.00118	CcSEcCtD
Vorinostat—Diarrhoea—Methotrexate—psoriatic arthritis	0.000211	0.00114	CcSEcCtD
Vorinostat—HDAC9—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000211	0.0212	CbGpPWpGaD
Vorinostat—Dizziness—Methotrexate—psoriatic arthritis	0.000204	0.00111	CcSEcCtD
Vorinostat—HDAC4—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000202	0.0202	CbGpPWpGaD
Vorinostat—Vomiting—Methotrexate—psoriatic arthritis	0.000197	0.00106	CcSEcCtD
Vorinostat—Headache—Methotrexate—psoriatic arthritis	0.000194	0.00105	CcSEcCtD
Vorinostat—HDAC8—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000186	0.0186	CbGpPWpGaD
Vorinostat—Nausea—Methotrexate—psoriatic arthritis	0.000184	0.000994	CcSEcCtD
Vorinostat—HDAC1—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000177	0.0177	CbGpPWpGaD
Vorinostat—HDAC4—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000175	0.0175	CbGpPWpGaD
Vorinostat—HDAC9—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000174	0.0174	CbGpPWpGaD
Vorinostat—HDAC3—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000157	0.0157	CbGpPWpGaD
Vorinostat—HDAC9—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000151	0.0151	CbGpPWpGaD
Vorinostat—HDAC1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.000147	0.0147	CbGpPWpGaD
Vorinostat—HDAC3—Transcriptional regulation of white adipocyte differentiation—TNF—psoriatic arthritis	0.000145	0.0145	CbGpPWpGaD
Vorinostat—NCOR1—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000144	0.0144	CbGpPWpGaD
Vorinostat—HDAC3—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000136	0.0136	CbGpPWpGaD
Vorinostat—NCOR1—Transcriptional regulation of white adipocyte differentiation—TNF—psoriatic arthritis	0.000133	0.0133	CbGpPWpGaD
Vorinostat—NCOR1—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000125	0.0125	CbGpPWpGaD
Vorinostat—HDAC1—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000117	0.0117	CbGpPWpGaD
Vorinostat—HDAC1—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000102	0.0102	CbGpPWpGaD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	9.18e-05	0.00919	CbGpPWpGaD
Vorinostat—NCOR1—Adipogenesis—TNF—psoriatic arthritis	8.77e-05	0.00877	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	8.35e-05	0.00835	CbGpPWpGaD
Vorinostat—HDAC2—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	7.56e-05	0.00756	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—NOS2—psoriatic arthritis	6.55e-05	0.00655	CbGpPWpGaD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	6.18e-05	0.00618	CbGpPWpGaD
Vorinostat—HDAC11—Disease—NOS2—psoriatic arthritis	5.34e-05	0.00534	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—NOS2—psoriatic arthritis	4.86e-05	0.00486	CbGpPWpGaD
Vorinostat—HDAC6—Disease—NOS2—psoriatic arthritis	4.47e-05	0.00448	CbGpPWpGaD
Vorinostat—HDAC4—Disease—NOS2—psoriatic arthritis	4.05e-05	0.00405	CbGpPWpGaD
Vorinostat—HDAC8—Disease—NOS2—psoriatic arthritis	3.73e-05	0.00374	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NOS2—psoriatic arthritis	3.49e-05	0.0035	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—TNF—psoriatic arthritis	3.28e-05	0.00328	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NOS2—psoriatic arthritis	3.14e-05	0.00314	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NOS2—psoriatic arthritis	3.13e-05	0.00313	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—TNF—psoriatic arthritis	3.01e-05	0.00302	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NOS2—psoriatic arthritis	2.88e-05	0.00289	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOS2—psoriatic arthritis	2.35e-05	0.00235	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS2—psoriatic arthritis	1.51e-05	0.00152	CbGpPWpGaD
